Aware Super Pty Ltd as trustee of Aware Super Purchases Shares of 7,926 Centene Corporation $CNC

Aware Super Pty Ltd as trustee of Aware Super purchased a new stake in Centene Corporation (NYSE:CNC) during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 7,926 shares of the company’s stock, valued at approximately $259,000.

Other institutional investors have also recently modified their holdings of the company. SouthState Bank Corp raised its holdings in shares of Centene by 1.3% in the first quarter. SouthState Bank Corp now owns 24,013 shares of the company’s stock worth $786,000 after acquiring an additional 317 shares during the last quarter. Calamos Wealth Management LLC acquired a new stake in shares of Centene during the first quarter valued at $338,000. Calamos Advisors LLC increased its position in Centene by 9.2% during the 1st quarter. Calamos Advisors LLC now owns 122,805 shares of the company’s stock worth $4,021,000 after purchasing an additional 10,312 shares in the last quarter. Bleakley Financial Group LLC raised its stake in Centene by 19.9% in the 1st quarter. Bleakley Financial Group LLC now owns 13,537 shares of the company’s stock valued at $443,000 after purchasing an additional 2,245 shares during the last quarter. Finally, Principal Financial Group Inc. lifted its holdings in Centene by 1.0% in the 1st quarter. Principal Financial Group Inc. now owns 520,999 shares of the company’s stock valued at $17,058,000 after purchasing an additional 5,088 shares in the last quarter. 93.63% of the stock is currently owned by institutional investors and hedge funds.

Centene Price Performance

Shares of Centene stock opened at $66.29 on Friday. The business’s fifty day moving average price is $62.76 and its 200 day moving average price is $48.85. Centene Corporation has a twelve month low of $25.08 and a twelve month high of $69.36. The company has a current ratio of 1.12, a quick ratio of 1.12 and a debt-to-equity ratio of 0.76. The stock has a market capitalization of $32.73 billion, a P/E ratio of -5.04, a PEG ratio of 0.52 and a beta of 1.07.

Centene (NYSE:CNC) last released its quarterly earnings data on Tuesday, April 28th. The company reported $3.37 EPS for the quarter, topping analysts’ consensus estimates of $2.23 by $1.14. Centene had a positive return on equity of 5.57% and a negative net margin of 3.25%.The company had revenue of $49.94 billion for the quarter, compared to the consensus estimate of $47.53 billion. During the same period last year, the business posted $2.90 EPS. The company’s quarterly revenue was up 7.1% compared to the same quarter last year. As a group, research analysts anticipate that Centene Corporation will post 3.44 earnings per share for the current year.

Wall Street Analyst Weigh In

A number of equities analysts have recently weighed in on CNC shares. Barclays reissued an “overweight” rating on shares of Centene in a research report on Tuesday, June 16th. Cantor Fitzgerald lifted their target price on shares of Centene from $60.00 to $75.00 and gave the stock an “overweight” rating in a research note on Tuesday, July 7th. Bank of America boosted their price target on Centene from $72.00 to $74.00 and gave the company a “buy” rating in a report on Thursday, June 4th. Truist Financial increased their price target on Centene from $71.00 to $78.00 and gave the stock a “buy” rating in a research note on Tuesday, July 14th. Finally, Oppenheimer raised their price objective on Centene from $58.00 to $67.00 and gave the stock an “outperform” rating in a report on Wednesday, May 27th. Seven research analysts have rated the stock with a Buy rating, eleven have given a Hold rating and two have assigned a Sell rating to the company’s stock. According to data from MarketBeat, the stock has a consensus rating of “Hold” and an average price target of $64.61.

Centene Profile

Centene Corporation (NYSE: CNC) is a diversified, multi-national healthcare enterprise that specializes in providing services to government-sponsored and national health programs. The company primarily acts as a managed care organization, delivering healthcare coverage and administering benefits for Medicaid, the Children’s Health Insurance Program (CHIP), Medicare Advantage, and individual marketplace plans. Centene also contracts with federal and state agencies to manage specialty care programs and community-based services for vulnerable populations.

Centene’s offerings extend beyond traditional insurance to include a range of specialty and support services.